drugset
drugset / Trial / NCT03671941

Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers

NCT03671941 ↗

Phase 1 Completed 31 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-label, single dose, crossover study to evaluate pharmacokinetic profiles and safety/tolerability of CKD-357 in healthy volunteers

Timeline

Start
2018-05-25
Primary completion
2018-06-04
Completion
2018-06-18

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-357 Unknown — Oral
Comparator Ticagrelor Small molecule — Oral

Indications

acute coronary syndrome